Egfr-mutant Non-small Cell Lung Cancer

• CLINICAL_TRIALS research · 2026-04-22
  Clinical Trial Update: Efficacy and Safety of SKB264 Plus Anlotinib in EGFR-TKI-Resistant Advanced NSCLC With Liver Metastasis [Phase 2]

  A Phase 2 clinical trial evaluating the combination of SKB264 and Anlotinib for EGFR-TKI-resistant advanced non-small cell lung cancer with …

• CLINICAL_TRIALS research · 2026-03-03
  Clinical Trial Update: OSIREAL - Osimertinib RWE on EGFRm NSCLC in Spain

  This entry reports the OSIREAL real-world evidence trial of Osimertinib for EGFR-mutant non-small cell lung cancer in Spain, sponsored by As…

• CLINICAL_TRIALS research · 2026-01-16
  Clinical Trial Update: Study of EGF816 in Combination With Selected Targeted Agents in EGFR-mutant NSCLC [Phase 1]

  A Phase 1 trial evaluating EGF816 in combination with selected targeted agents for EGFR-mutant non-small cell lung cancer; the study is curr…

• CLINICAL_TRIALS research · 2026-01-07
  Clinical Trial Update: Neoadjuvant Sacituzumab Tirumotecan and Limertinib for Potentially Resectable Stage Ⅲ EGFR-mutant Non-small Cell Lung Cancer [Phase 2]

  A Phase 2 neoadjuvant trial is investigating sacituzumab tirumotecan with limertinib for potentially resectable stage III EGFR-mutant non-sm…

• CLINICAL_TRIALS research · 2025-05-16
  Clinical Trial Update: A Phase 1/2 Study to Evaluate the Safety, Tolerability and PK of JIN-A02 in Patients With EGFR Mutant Advanced NSCLC [Phase 1, Phase 2]

  This document describes a Phase 1/2 clinical trial evaluating the safety, tolerability, and pharmacokinetics of JIN-A02 in patients with EGF…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS research · 2024-08-16
  Clinical Trial Update: CSF CTC-Capture-Guided EGFR-TKI and Bevacizumab Combination Therapy in EGFR-Mutant Advanced NSCLC [EARLY_Phase 1]

  An early-phase (Phase 1) clinical trial update evaluating a CSF CTC-capture-guided combination of EGFR-TKI and bevacizumab in EGFR-mutant ad…